Brain signals less satisfaction for obese people, research shows

October 16, 2008

AUSTIN, Texas--Obese individuals may overeat because they experience less satisfaction from eating food due to a reduced response in their brains' reward circuitry, according to a new study by Eric Stice, psychology researcher at The University of Texas at Austin.

While eating, the body releases dopamine, a neurotransmitter in the reward centers of the brain, but Stice found obese people show less activation in the striatum relative to lean people. He also found individuals with a blunted response were more likely to show unhealthy weight gain, particularly if they had a gene associated with compromised dopamine signaling in the brain's reward circuitry.

Stice and a team of researchers have published their findings in the Science article, "Relation Between Obesity and Blunted Striatal Response to Food is Moderated by TaqIA A1 Allele."

Although research has revealed biological factors play a major role in causing obesity, few studies have identified factors that increase people's risk to gain weight in the future.

With support from the National Institutes of Health, Stice led a research team-comprising clinical psychologists from the university and Oregon Research Institute and sensory scientists from the John B. Pierce Laboratory and Yale University--to explore how blunted responses in the brain relate to weight gain in young females.

"The research reveals obese people may have fewer dopamine receptors, so they overeat to compensate for this reward deficit," Stice, who has studied eating disorders and obesity for almost two decades, said. "People with fewer D2 receptors need to take in more of a rewarding substance--such as food or drugs--to experience the same level of pleasure as other people."

Using Functional Magnetic Resonance Imaging (fMRI), Stice's team measured how the dorsal striatum was activated in response to the taste of a chocolate milkshake (versus a tasteless solution). The researchers also tested participants for the presence of a genetic variation linked to a lower number of dopamine D2 receptors, the Taq1A1 allele.

For one year, the researchers tracked participants' changes in body mass index. The results revealed participants with decreased striatal activation in response to the milkshake who also had the A1 allele were more likely to gain weight over time.

"Understanding the abnormalities in activation of reward circuitry in response to eating is critical to helping people regulate their weight because dopamine serves as the primary neurotransmitter in the reward pathways of the brain," Stice said. "Although people with decreased sensitivity of reward circuitry are at increased risk for unhealthy weight gain, identifying changes in behavior or pharmacological options could correct this reward deficit to prevent and treat obesity."
-end-
Christian Clarke Casarez, director of public affairs, College of Liberal Arts, 512-471-4945 or christianc@mail.utexas.edu

University of Texas at Austin

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.